| Phase 14 trials |
|
Phase 1
|
NCT00459212 |
Mar 2007 → Dec 2010 |
acute myeloid leukemia with 11q23 abnormalities, acute myeloid leukemia with t(8;21)(q22;q22) translocation, acute myeloid leukemia, inv(16)(p13.1;q22), acute myeloid leukemia, t(16;16)(p13.1;q22) +4 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00084643 |
May 2004 → Apr 2008 |
malignant colon neoplasm, rectal cancer |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00078962 |
Jan 2004 → Nov 2007 |
cancer of unknown primary site |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00070551 |
Sep 2003 → Feb 2009 |
acute myeloid leukemia with 11q23 abnormalities, acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22), acute myeloid leukemia with t(8;21)(q22;q22) translocation |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
| Phase 1/22 trials |
|
Phase 1/2
|
NCT00074022 |
Oct 2003 → Nov 2007 |
non-small cell lung carcinoma, prostate carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00056173 |
Mar 2002 → Dec 2004 |
metastatic neoplasm, renal cell carcinoma |
Aptose Biosciences Inc. |
Completed
|
No outcome recorded
|
| Phase 23 trials |
|
Phase 2
|
NCT00565058 |
Aug 2007 → Sep 2009 |
acute myeloid leukemia |
Aptose Biosciences Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00087165 |
Jan 2005 → Sep 2006 |
prostate cancer |
University Health Network, Toronto |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00068588 |
Oct 2003 → Mar 2010 |
male breast carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|